FONG Kin Chiu
No ORCID on file
· 102 papers in corpus
· active 2004-2007
Frequent coauthors
- DODGE JEFFREY ALAN 102
- DALLY ROBERT DEAN 102
- Frank Scott Alan 102
- HUMMEL CONRAD WILSON 102
- JONES SCOTT ALAN 102
- LEWIS GEORGE SAL 102
- Shepherd Timothy Alan 102
- WALLACE OWEN BRENDAN 102
2007
Disclosed are selective estrogen receptor modulators containing a phenylsulfonyl group that are represented by formula (I) wherein the variables are as defined in the specification, a pharmaceutical acid addition salt thereof these compound…
2007
Disclosed are selective estrogen receptor modulators containing a phenylsulfonyl group that are represented by formula (I) wherein the variables are as defined in the specification, a pharmaceutical acid addition salt thereof these compound…
2007
The present invention relates to a selective estrogen receptor modulator of formula I: or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and/or uterine leiomyoma/leiomyomata.
2007
Disclosed are selective estrogen receptor modulators containing a phenylsulfonyl group that are represented by formula (I) wherein the variables are as defined in the specification, a pharmaceutical acid addition salt thereof these compound…
2007
The present invention relates to a selective estrogen receptor modulator of formula I: or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and/or uterine leiomyoma/leiomyomata.
2007
The present invention relates to a selective estrogen receptor modulator of formula I: or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and/or uterine leiomyoma/leiomyomata.
2007
The present invention relates to a selective estrogen receptor modulator of formula I: or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and/or uterine leiomyoma/leiomyomata.
2007
Disclosed are selective estrogen receptor modulators containing a phenylsulfonyl group that are represented by formula (I) wherein the variables are as defined in the specification, a pharmaceutical acid addition salt thereof these compound…
2007
The present invention relates to a selective estrogen receptor modulator of formula I: or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and/or uterine leiomyoma/leiomyomata.
2007
Disclosed are selective estrogen receptor modulators containing a phenylsulfonyl group that are represented by formula (I) wherein the variables are as defined in the specification, a pharmaceutical acid addition salt thereof these compound…
2007
Disclosed are selective estrogen receptor modulators containing a phenylsulfonyl group that are represented by formula (I) wherein the variables are as defined in the specification, a pharmaceutical acid addition salt thereof these compound…
2007
Disclosed are selective estrogen receptor modulators containing a phenylsulfonyl group that are represented by formula (I) wherein the variables are as defined in the specification, a pharmaceutical acid addition salt thereof these compound…
2007
The present invention relates to a selective estrogen receptor modulator of formula I: or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and/or uterine leiomyoma/leiomyomata.
2007
The present invention relates to a selective estrogen receptor modulator of formula I: or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and/or uterine leiomyoma/leiomyomata.
2007
Disclosed are selective estrogen receptor modulators containing a phenylsulfonyl group that are represented by formula (I) wherein the variables are as defined in the specification, a pharmaceutical acid addition salt thereof these compound…
2007
Disclosed are selective estrogen receptor modulators containing a phenylsulfonyl group that are represented by formula (I) wherein the variables are as defined in the specification, a pharmaceutical acid addition salt thereof these compound…
2007
Disclosed are selective estrogen receptor modulators containing a phenylsulfonyl group that are represented by formula (I) wherein the variables are as defined in the specification, a pharmaceutical acid addition salt thereof these compound…
2007
The present invention relates to a selective estrogen receptor modulator of formula I: or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and/or uterine leiomyoma/leiomyomata.
2007
The present invention relates to a selective estrogen receptor modulator of formula I: or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and/or uterine leiomyoma/leiomyomata.
2007
The present invention relates to a selective estrogen receptor modulator of formula I: or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and/or uterine leiomyoma/leiomyomata.
2007
The present invention relates to a selective estrogen receptor modulator of formula I: or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and/or uterine leiomyoma/leiomyomata.
2007
Disclosed are selective estrogen receptor modulators containing a phenylsulfonyl group that are represented by formula (I) wherein the variables are as defined in the specification, a pharmaceutical acid addition salt thereof these compound…
2007
Disclosed are selective estrogen receptor modulators containing a phenylsulfonyl group that are represented by formula (I) wherein the variables are as defined in the specification, a pharmaceutical acid addition salt thereof these compound…
2007
The present invention relates to a selective estrogen receptor modulator of formula I: or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and/or uterine leiomyoma/leiomyomata.
2007
Disclosed are selective estrogen receptor modulators containing a phenylsulfonyl group that are represented by formula (I) wherein the variables are as defined in the specification, a pharmaceutical acid addition salt thereof these compound…